Shedir Pharma Group SpA (MIL:SHE) EV-to-EBIT : 5.40 (As of May. 10, 2025)

View and export this data going back to 2019. Start your Free Trial

What is Shedir Pharma Group SpA EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Shedir Pharma Group SpA's Enterprise Value is €47.75 Mil. Shedir Pharma Group SpA's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was €8.84 Mil. Therefore, Shedir Pharma Group SpA's EV-to-EBIT for today is 5.40.

The historical rank and industry rank for Shedir Pharma Group SpA's EV-to-EBIT or its related term are showing as below:

MIL:SHE' s EV-to-EBIT Range Over the Past 10 Years
Min: 4.25 Med: 6.85 Max: 17.13
Current: 5.4

During the past 7 years, the highest EV-to-EBIT of Shedir Pharma Group SpA was 17.13. The lowest was 4.25. And the median was 6.85.

MIL:SHE's EV-to-EBIT is not ranked
in the Drug Manufacturers industry.
Industry Median: 16.265 vs MIL:SHE: 5.40

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Shedir Pharma Group SpA's Enterprise Value for the quarter that ended in Jun. 2024 was €37.08 Mil. Shedir Pharma Group SpA's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was €8.84 Mil. Shedir Pharma Group SpA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 23.84%.

Shedir Pharma Group SpA EV-to-EBIT Historical Data

The historical data trend for Shedir Pharma Group SpA's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shedir Pharma Group SpA EV-to-EBIT Chart

Shedir Pharma Group SpA Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

16.74

7.90

7.91

4.36

6.41

Shedir Pharma Group SpA Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EV-to-EBIT	Get a 7-Day Free Trial									-	4.36	-	6.41	-

Competitive Comparison of Shedir Pharma Group SpA's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Shedir Pharma Group SpA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shedir Pharma Group SpA's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shedir Pharma Group SpA's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Shedir Pharma Group SpA's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

Shedir Pharma Group SpA EV-to-EBIT Calculation

Shedir Pharma Group SpA's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	47.754	/	8.837
	=	5.40

Shedir Pharma Group SpA's current Enterprise Value is €47.75 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shedir Pharma Group SpA's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was €8.84 Mil.

Shedir Pharma Group SpA (MIL:SHE) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Shedir Pharma Group SpA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2024 )	=	EBIT	/	Enterprise Value (Q: Jun. 2024 )
	=	8.837	/	37.07522
	=	23.84 %

Shedir Pharma Group SpA's Enterprise Value for the quarter that ended in Jun. 2024 was €37.08 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shedir Pharma Group SpA's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was €8.84 Mil.

Shedir Pharma Group SpA EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Shedir Pharma Group SpA's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Shedir Pharma Group SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shedir Pharma Group SpA (MIL:SHE) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

95 - Piano di Sorrento, Via Bagnulo, Naples, ITA, 80063

Website

http://www.shedirpharma.com

Shedir Pharma Group SpA is engaged in manufacturing of nutraceuticals, cosmetics and medical devices. Its products are divided into four lines Shedir , Deimos, Phobos, and Menkar. The company's products include capsules, softgels, swallowable and chewable tablets, orosoluble powders, granules, oral solutions, drops for oral use, sprays for oral, sublingual and nasal use, Creams and gels for cosmetic use, and Spray for topical use.